Conference Coverage: ASCO 2023 – Focus on Genitourinary Malignancies (GU)

Impact of recent ASCO data on clinical practice and therapy guidance in genitourinary cancers

June 9, 2023

Faculty Chair

Daniel Petrylak, MD

Yale University, New Haven, CT, USA


Joaquim Bellmunt, MD, PhD
Harvard Medical School, Boston, MA, USA

Robert Dreicer, MD, MACP, FASCO
University of Virginia Cancer Center, Charlottesville, VA, USA

Karim Fizazi, MD, PhD
Institute Gustave Roussy, Villejuif, France

Leonard G. Gomella, MD, FACS
Jefferson University Hospitals, Philadelphia, PA, USA

Thomas Powles, MD,  MRCP, MBBS
Barts Cancer Institute, London, UK

Oliver Sartor, MD
Tulane Medical Center, New Orleans, LA, USA

Susan Slovin, MD, PhD
Memorial Sloan Kettering Cancer Center, New York, NY, USA

Scott Tagawa, MD, FACP
Weill Cornell Medical Center, New York, NY, USA


Download the meeting agenda

View Agenda

Sample Report

Start discovering the insights

View Report


  • Standard and Emerging Therapies in Prostate Cancer
  • Targeting DNA Repair in mCRPC
  • Immunotherapies in Bladder Cancer
  • Targeted Therapies in Bladder Cancer
  • Clear Cell Renal Cell Carcinoma
  • Non-Clear Cell Renal Cell Carcinoma

Purchase Report

Thank you for your interest in our insights.

Complete the form below to receive additional information.